Literature DB >> 20582295

Depression and failure of cholesterol lowering after acute myocardial infarction.

Jeff C Huffman1, Felicia A Smith, Gregory L Fricchione, James L Januzzi, Sara Nadelman, William F Pirl.   

Abstract

OBJECTIVE: Depression after acute myocardial infarction (MI) is independently associated with cardiac mortality, but the mechanism explaining this association remains unclear. To our knowledge, there has been no prior study exploring the impact of post-MI depression on lipid lowering, a key secondary prevention measure in post-MI patients. In this prospective observational cohort pilot study, we hypothesized that patients with early post-MI depression would have inferior cholesterol reduction 6 months post-MI compared to nondepressed patients.
METHOD: Patients admitted to a cardiac intensive care unit or a cardiac step-down unit between October 2003 and July 2005 were enrolled in the study within 72 hours of MI. Two weeks post-MI, subjects were assessed for depression using the module for current major depressive disorder (MDD) from the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) and the Beck Depression Inventory-II (BDI-II). Information regarding cholesterol levels was collected 6 months after MI.
RESULTS: Initial and 6-month cholesterol levels were available for 70 subjects who had 2-week post-MI depression assessments. Post-MI depression, measured both using an interview for MDD and the BDI-II, was associated with inferior cholesterol reduction, with depressed subjects improving their cholesterol levels by approximately 8 mg/dL compared to a cholesterol reduction of 37 mg/dL in nondepressed subjects. Furthermore, depression diagnosed by formal MDD interview (beta=-.301; P<.001) and the BDI-II (beta=-.269; P=.001) continued to be associated with significantly smaller reductions in cholesterol levels on linear regression analyses that accounted for demographic and medical variables.
CONCLUSIONS: In this exploratory pilot study, early post-MI depression was independently associated with impaired lipid lowering 6 months after MI.

Entities:  

Year:  2010        PMID: 20582295      PMCID: PMC2882811          DOI: 10.4088/PCC.08m00766blu

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  15 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models.

Authors:  Michael A Babyak
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

3.  Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction.

Authors:  R C Ziegelstein; J A Fauerbach; S S Stevens; J Romanelli; D P Richter; D E Bush
Journal:  Arch Intern Med       Date:  2000-06-26

4.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

Authors:  François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

Review 5.  Future therapeutic targets in mood disorders: the glucocorticoid receptor.

Authors:  R McQuade; A H Young
Journal:  Br J Psychiatry       Date:  2000-11       Impact factor: 9.319

Review 6.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors: 
Journal:  Eur Heart J       Date:  2000-09       Impact factor: 29.983

7.  Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis.

Authors:  Joost P van Melle; Peter de Jonge; Titia A Spijkerman; Jan G P Tijssen; Johan Ormel; Dirk J van Veldhuisen; Rob H S van den Brink; Maarten P van den Berg
Journal:  Psychosom Med       Date:  2004 Nov-Dec       Impact factor: 4.312

8.  Predictors of attendance at cardiac rehabilitation after myocardial infarction.

Authors:  D Lane; D Carroll; C Ring; D G Beevers; G Y Lip
Journal:  J Psychosom Res       Date:  2001-09       Impact factor: 3.006

9.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors: 
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

10.  Predictors of weight change in overweight patients with myocardial infarction.

Authors:  Yazid Y Fadl; Harlan M Krumholz; Mikhail Kosiborod; Frederick A Masoudi; Pamela N Peterson; Kimberly J Reid; William S Weintraub; Donna M Buchanan; John A Spertus
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

View more
  3 in total

Review 1.  Depression and Anxiety in Heart Failure: A Review.

Authors:  Christopher M Celano; Ana C Villegas; Ariana M Albanese; Hanna K Gaggin; Jeff C Huffman
Journal:  Harv Rev Psychiatry       Date:  2018 Jul/Aug       Impact factor: 3.732

2.  The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.

Authors:  Jeff C Huffman; Christopher M Celano; James L Januzzi
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

3.  Depression and cardiac disease: epidemiology, mechanisms, and diagnosis.

Authors:  Jeff C Huffman; Christopher M Celano; Scott R Beach; Shweta R Motiwala; James L Januzzi
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.